@FierceMedDev: As the debate over the device tax continues, a hospital group warns that devicemakers might try to game the system: Story | Follow @FierceMedDev
@MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce
@DamianFierce: Rivals St. Jude and Medtronic are at it again, this time over study results for $STJ's EnligHTN More | Follow @DamianFierce
> NextGen, which has operations in the U.K. and Michigan, is launching a new assay designed to identify diagnostic biomarkers in brain disorders. Release
> The Penn State Research Foundation has inked a deal with device firm Minnetronix to provide wireless energy technology for left ventricular assist devices. Story
> Embrace is using its partnership with GE Healthcare ($GE) to provide affordable infant warmers to the developing world, and the company is partnering with NGOs around the world to get the product into needy hands. Report
> Massachusetts is planning to bolster its life sciences industry with a $28 million biotech facility in Fall River, managed by UMass. News
> CBS Atlanta has taken a closer look at the effects of 2010's recall of the DePuy's ASR XL hip replacement. Item
Pharma News
@FiercePharma: Momenta tops Boston Globe list of best-performing companies. Generic Lovenox made the difference. Story | Follow @FiercePharma
@EricPFierce: What leads many employers' concerns for drug benefits? The huge jump in specialty drug expense for starters. Piece | Follow @EricPFierce
> Generic floodgates open for Plavix in U.S. Article
> Warner Chilcott sues Watson to stop generic contraceptive. News
> Employers eye costs of specialty drugs. Story
> Drugmakers rail against India's move toward price controls. More
Biotech News
@FierceBiotech: Gene therapy = fountain of youth in mice. Article | Follow @FierceBiotech
@RyanMFierce: Osiris got a "first" ever nod for a stem-cell drug in Canada, but the business implications appear small. More | Follow @RyanMFierce
> The R&D revolution wants you. More
> New cloud hovers over class of 'good cholesterol' drugs. Story
> Kleiner Perkins to back early-stage biotechs with $525M fund. Article
> Allergan to enlist new hires in R&D expansion. News
> Canada hands Osiris historic approval for stem-cell drug. Report